Physical Exercise with or without Whole-Body Vibration in Breast Cancer Patients Suffering from Aromatase Inhibitor-Induced Musculoskeletal Symptoms: A Pilot Randomized Clinical Study.

aromatase inhibitors breast cancer pain physical exercise precision medicine quality of life whole-body vibration

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
14 Dec 2021
Historique:
received: 12 11 2021
revised: 28 11 2021
accepted: 10 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 25 12 2021
Statut: epublish

Résumé

In this study, we aimed to assess the safety and efficacy of physical exercise, with or without whole-body vibration (WBV), in patients with aromatase inhibitor-induced musculoskeletal symptoms (AIMSS). Eligible patients were adults (≥18 years) with a history of breast cancer and current AIMSS. Enrolled patients (

Identifiants

pubmed: 34945841
pii: jpm11121369
doi: 10.3390/jpm11121369
pmc: PMC8707128
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur J Phys Rehabil Med. 2015 Oct;51(5):513-20
pubmed: 25990196
Med Sci Sports. 1973 Summer;5(2):94-6
pubmed: 4721013
Front Oncol. 2020 Jun 16;10:864
pubmed: 32612947
Medicine (Baltimore). 2018 Sep;97(38):e12534
pubmed: 30235777
BMC Cancer. 2018 Jan 10;18(1):62
pubmed: 29316888
Cochrane Database Syst Rev. 2017 Sep 26;9:CD011755
pubmed: 28950401
Exerc Sport Sci Rev. 2003 Jan;31(1):3-7
pubmed: 12562163
Front Oncol. 2020 Nov 18;10:620574
pubmed: 33312961
Neuroreport. 2001 Jul 3;12(9):2021-5
pubmed: 11435940
Disabil Rehabil. 2021 Jul 5;:1-9
pubmed: 34225557
Age Ageing. 2018 May 1;47(3):367-373
pubmed: 29471456
Breast Cancer Res Treat. 2012 Jul;134(2):459-78
pubmed: 22689091
Science. 1965 Nov 19;150(3699):971-9
pubmed: 5320816
Mol Cell Biochem. 2021 Jun;476(6):2449-2464
pubmed: 33599895
J Back Musculoskelet Rehabil. 2021 Jun 4;:
pubmed: 34092604
Cancer. 2019 Sep 1;125(17):3059-3067
pubmed: 31067357
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4476-4485
pubmed: 32373985
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8028-8035
pubmed: 32767329
Acupunct Med. 2013 Sep;31(3):264-71
pubmed: 23722951
J Neurosci. 1994 Jul;14(7):4095-108
pubmed: 8027764
Nutrition. 2010 May;26(5):542-50
pubmed: 19804953
Clin Exp Rheumatol. 2010 Nov-Dec;28(6 Suppl 63):S40-5
pubmed: 21122265
J Clin Oncol. 2010 Mar 1;28(7):1154-60
pubmed: 20100963
Breast Cancer Res Treat. 2011 Apr;126(2):529-37
pubmed: 20803066
Work. 2018;59(4):571-583
pubmed: 29733043
Lancet. 2002 Jun 22;359(9324):2131-9
pubmed: 12090977
Oncol Rev. 2015 Feb 10;9(1):263
pubmed: 26779309
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Cancer Manag Res. 2020 Jan 30;12:675-686
pubmed: 32099464
Physiotherapy. 2018 Dec;104(4):400-407
pubmed: 30477677
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Arch Phys Med Rehabil. 2019 Nov;100(11):2167-2178
pubmed: 31004565
N Engl J Med. 2004 Mar 11;350(11):1081-92
pubmed: 15014181
J Diabetes Metab Disord. 2019 Dec 21;19(1):61-69
pubmed: 32550157
Sports Med. 2007;37(1):1-14
pubmed: 17190532
Geriatr Nurs. 2016 Mar-Apr;37(2):116-21
pubmed: 26694694
J Clin Oncol. 2007 Sep 1;25(25):3877-83
pubmed: 17761973
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1259-65
pubmed: 22496538
Breast Cancer Res Treat. 2010 Jan;119(1):111-8
pubmed: 19655244
Biomed Res Int. 2021 Mar 26;2021:6671390
pubmed: 33855078
J Clin Oncol. 2015 Apr 1;33(10):1104-11
pubmed: 25452437
Lancet Oncol. 2008 Sep;9(9):866-72
pubmed: 18703382
Integr Cancer Ther. 2018 Sep;17(3):968-978
pubmed: 29952241
J Biol Regul Homeost Agents. 2021 Feb 4;35(1):397-402
pubmed: 33538147
J Cancer Surviv. 2016 Aug;10(4):654-62
pubmed: 26782031
Support Care Cancer. 2013 Apr;21(4):1077-87
pubmed: 23111941
Physiother Theory Pract. 2020 Dec;36(12):1348-1353
pubmed: 30704332
Osteoarthritis Cartilage. 2003 Aug;11(8):551-60
pubmed: 12880577
BMC Sports Sci Med Rehabil. 2020 Dec 10;12(1):78
pubmed: 33303024
Front Physiol. 2021 Apr 13;12:664991
pubmed: 33927646
Arch Phys Med Rehabil. 2015 Aug;96(8):1525-32
pubmed: 25827655
Disabil Rehabil. 2012;34(11):883-93
pubmed: 22225483
Cochrane Database Syst Rev. 2020 Jan 29;1:CD012988
pubmed: 31994181
Curr Oncol Rep. 2021 Apr 14;23(6):63
pubmed: 33852059

Auteurs

Alessandro de Sire (A)

Physical and Rehabilitative Medicine Unit, Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy.

Lorenzo Lippi (L)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.

Antonio Ammendolia (A)

Physical and Rehabilitative Medicine Unit, Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy.

Carlo Cisari (C)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.

Konstantinos Venetis (K)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Division of Pathology, IEO, European Institute of Oncology IRCCS, 20144 Milan, Italy.

Elham Sajjadi (E)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Division of Pathology, IEO, European Institute of Oncology IRCCS, 20144 Milan, Italy.

Nicola Fusco (N)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Division of Pathology, IEO, European Institute of Oncology IRCCS, 20144 Milan, Italy.

Marco Invernizzi (M)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.
Translational Medicine, Dipartimento Attività Integrate Ricerca e Innovazione (DAIRI), Azienda Ospedaliera SS, Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.

Classifications MeSH